BoNT/A seems to be a promising alternative in the treatment of BPH-related LUTS with a good tolerance and safety profile. However, the level of evidence is still low and further randomized controlled studies are mandatory
The increasing body of evidence and number of potential indications for the use of botulinum neuroto...
OnabotulinumtoxinA (BoNT-A) was first used to treat neurogenic lower urinary tract dysfunction (LUTD...
Study Type--Therapy (prospective cohort) Level of Evidence 3a. What's known on the subject? and What...
Botulinum toxin is a neurotoxin produced by the bacterium Clostridium botulinum. It inhibits the rel...
Context: The intraprostatic injection of botulinum neurotoxin type A (BoNT-A) is a minimally invasiv...
Purpose of review The injection of botulinum neurotoxin A (BoNT-A) into the prostate represents an a...
AbstractBotulinum neurotoxins (BoNTs) are known for their ability to induce chemical denervation, mo...
Botulinum neurotoxin (BoNT) is used to treat a variety of ailments, and its therapeutic application ...
Background: Lower Urinary Tract Symptoms (LUTS) in men are a common clinical problem in urology and ...
Several studies have demonstrated the efficacy of intraprostatic injection of botulinum neurotoxin t...
Lower urinary tract symptoms (LUTS) in men with small benign prostatic hyper-plasia (BPH) might not ...
Abstract Botulinum neurotoxin (BoNT) has been called the most poisonous poison and a potential biot...
Purpose. To assess the efficacy and safety of intraprostatic injection of two botulinum neurotoxin t...
Background/PurposeLower urinary tract symptoms (LUTS) in men with small benign prostatic hyper-plasi...
In recent years, there has been an increased interest in the use of botulinum neurotoxin (BoNT) to t...
The increasing body of evidence and number of potential indications for the use of botulinum neuroto...
OnabotulinumtoxinA (BoNT-A) was first used to treat neurogenic lower urinary tract dysfunction (LUTD...
Study Type--Therapy (prospective cohort) Level of Evidence 3a. What's known on the subject? and What...
Botulinum toxin is a neurotoxin produced by the bacterium Clostridium botulinum. It inhibits the rel...
Context: The intraprostatic injection of botulinum neurotoxin type A (BoNT-A) is a minimally invasiv...
Purpose of review The injection of botulinum neurotoxin A (BoNT-A) into the prostate represents an a...
AbstractBotulinum neurotoxins (BoNTs) are known for their ability to induce chemical denervation, mo...
Botulinum neurotoxin (BoNT) is used to treat a variety of ailments, and its therapeutic application ...
Background: Lower Urinary Tract Symptoms (LUTS) in men are a common clinical problem in urology and ...
Several studies have demonstrated the efficacy of intraprostatic injection of botulinum neurotoxin t...
Lower urinary tract symptoms (LUTS) in men with small benign prostatic hyper-plasia (BPH) might not ...
Abstract Botulinum neurotoxin (BoNT) has been called the most poisonous poison and a potential biot...
Purpose. To assess the efficacy and safety of intraprostatic injection of two botulinum neurotoxin t...
Background/PurposeLower urinary tract symptoms (LUTS) in men with small benign prostatic hyper-plasi...
In recent years, there has been an increased interest in the use of botulinum neurotoxin (BoNT) to t...
The increasing body of evidence and number of potential indications for the use of botulinum neuroto...
OnabotulinumtoxinA (BoNT-A) was first used to treat neurogenic lower urinary tract dysfunction (LUTD...
Study Type--Therapy (prospective cohort) Level of Evidence 3a. What's known on the subject? and What...
DOI
Add to ORKG